Latest Advances

  • Condition: Thalassemia
  • Journal: Blood advances
  • Treatment Used: Luspatercept
  • Number of Patients: 336
  • Published —
The study researched the use of luspatercept for patients with thalassemia.
  • Condition: Sickle Cell Disease
  • Journal: Blood advances
  • Treatment Used: Allogeneic Stem Cell Transplantation with Omidubicel
  • Number of Patients: 13
  • Published —
This study tested the safety and efficacy of using allogeneic stem cell transplantation with omidubicel to treat patients with sickle cell disease.
  • Condition: Chronically Transfused Patients with Thalassemia
  • Journal: Immunohematology
  • Treatment Used: Antigen-Matched Red Blood Cell Units
  • Number of Patients: 24
  • Published —
This study determined the benefits of antigen matched transfusion guided by DNA-based typing in chronically transfused patients with thalassemia (blood disorder).
  • Condition: Young Patient with Graves' Disease
  • Journal: Acta bio-medica : Atenei Parmensis
  • Treatment Used: Antithyroid Treatment
  • Number of Patients: 1
  • Published —
This article described the case of a young patient with Graves' disease (immune system disorder that results in the overproduction of thyroid hormones) treated with antithyroid (medication to prevent the thyroid from producing excess amounts of hormone) treatment.
  • Condition: Sickle Cell Disease and Thalassemia
  • Journal: Blood advances
  • Treatment Used: Stem Cell Transplant or Gene Therapy
  • Number of Patients: 517
  • Published —
This systematic review evaluated the quality of life in patients with sickle cell disease (SCD) and thalassemia after treatment with hematopoietic stem cell transplant (HSCT) or gene therapy.
  • Condition: Thalassemia
  • Journal: PloS one
  • Treatment Used: Iron Reduction Therapy
  • Number of Patients: 149
  • Published —
This study tested the safety and efficacy of using iron reduction therapy to treat patients with thalassemia.
  • Condition: Urate Nephropathy from Tumor Lysis Syndrome (TLS) in an Undiagnosed Case of Prostate Cancer
  • Journal: Current oncology (Toronto, Ont.)
  • Treatment Used: Urgent Hemodialysis
  • Number of Patients: 1
  • Published —
This case report describes a patient with metastatic prostate cancer which remained undiagnosed until the patient developed tumor lysis syndrome (TLS), leading to urate nephropathy treated with urgent hemodialysis.
  • Condition: ?-Thalassemia Major
  • Journal: Hemoglobin
  • Treatment Used: Calcium Channel Blockers(CCBs) in Conjunction with Standard Iron-Chelating Agents
  • Number of Patients: 210
  • Published —
This review of the literature investigated d the clinical effectiveness of calcium channel blockers (CCBs) in conjunction with chelation therapy for reducing iron overload in patients with thalassemia (blood disorder).
  • Condition: Atypical Hemolytic Uremic Syndrome
  • Journal: BMC nephrology
  • Treatment Used: Ravulizumab
  • Number of Patients: 8
  • Published —
The study researched the outcomes of ravulizumab for atypical hemolytic uremic syndrome triggered by pregnancy.
  • Condition: Autoimmune Cytopenia
  • Journal: Experimental oncology
  • Treatment Used: Various
  • Number of Patients: 83
  • Published —
In this study, researchers sought to determine the best treatment for autoimmune cytopenia due to chronic lymphocytic leukemia.
  • Condition: Adult Patients with Atypical Hemolytic-Uremic Syndrome (aHUS)
  • Journal: Terapevticheskii arkhiv
  • Treatment Used: Russian Biosimilar of the Drug Eculizumab
  • Number of Patients: 3
  • Published —
This study evaluated the effectiveness and safety of the Russian biosimilar (highly similar to another already approved biological medicine) of the drug eculizumab for adult patients with atypical hemolytic-uremic syndrome (disease that causes abnormal blood clots to form in small blood vessels in the kidneys; aHUS).
  • Condition: Relapsed/refractory Autoimmune Cytopenias
  • Journal: Hematology (Amsterdam, Netherlands)
  • Treatment Used: Tacrolimus
  • Number of Patients: 80
  • Published —
In this study, researchers evaluated the outcomes of using tacrolimus for the treatment of relapsed/refractory autoimmune cytopenias.
Showing 1-12 of 281